Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Ortega (La Jolla, CA, United States of America), E. Meyer (Philadelphia, PA, United States of America), G. Brusselle (Ghent, Belgium), K. Asano (Kanagawa, Japan), R. Price (Stevenage, Hertfordshire, United Kingdom), C. Prazma (Research Triangle Park, NC, United States of America), F. Albers (Research Triangle Park, NC, United States of America), S. Yancey (Research Triangle Park, NC, United States of America), G. Gleich (Utah, United States of America). Immunogenicity of Mepolizumab in Patients with Severe Eosinophilic Asthma: Experience from the Clinical Development Program. 1650

Member's Comments

No comment yet.

Related content which might interest you: Assessment of Efficacy Omalizumab Retreatment in Patients With Severe Asthma Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Effectiveness of Pulmonary Rehabilitation for Patients with Asthma: EPRA-RCT Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2018 Assessment of Severe Asthma Management Practices among Pulmonologists and Allergists Source: International Congress 2018 – Medical education via the web and the internet Year: 2018 The Impact of Current Smoking on Severe Asthma in the Wessex Severe Asthma Cohort Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019 What Can Be Expected From Pathology Assessment? Or: Is Severe Asthma Still an Eosinophilic Disease? Source: Research Seminar 2007 - Severe Asthma Year: 2007 Comparison of Eosinophilic and Non-eosinophilic Cases with Chronic Obstructive Pulmonary Disease (COPD) in terms of Clinical Arrival, Exacerbations, Quality of Life and Response to Treatment: A Prospective Study Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Cost Effectiveness Of Bronchial Thermoplasty For Treatment Of Severe Asthma Patients In Scotland Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017 How to Manage Severe Asthma, the Value of Inflammation Monitoring Source: Research Seminar 2007 - Severe Asthma Year: 2007 Problems of Importance in Severe Asthma: A Patient Perspective Source: International Congress 2019 – Person-centred approaches to COPD and asthma care Year: 2019 Real-world Omalizumab and Mepolizumab treated Difficult Asthma Phenotypes and their Clinical Outcomes Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Epidemiology and Triggers of Severe Asthma Source: Research Seminar 2007 - Severe Asthma Year: 2007 Safety and Efficacy of Omalizumab in Elderly Patients with Uncontrolled Allergic Asthma. Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Use of the Recombinant Tuberculosis Allergen in the Early Diagnosis of Tuberculosis in Paediatric Patients Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people Year: 2018 Late Breaking Abstract - Characteristics of Patients Diagnosed with Severe Asthma at UK Specialist Centres: Variation by Ethnicity Source: International Congress 2019 – Bronchiectasis Year: 2019 Clinical Features and Treatment Outcome of Carcinomatous Pericarditis due to Lung Cancer. Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018 Early Fever Associated with Clinical Outcomes in Patients with Coronavirus Disease 2019 Source: Virtual Congress 2021 – COVID - 19: lessons learned Year: 2021 International ERS/ATS Guidelines on Definition, Evaluation and Treatment of Severe Asthma Source: Guideline 2014 Year: 2014 Study to Evaluate Satisfaction with the Inhalation Device Used by Patients with Asthma or Chronic Obstructive Pulmonary Disease and the Association with Adherence and Disease Control Source: Virtual Congress 2020 – Novel insights into nursing interventions for managing patients with asthma and COPD Year: 2020 Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019